Cardiocast

AHA jewels, readmissions not best at ‘Best Hospitals,’ and more


 

From AHA 2018, an analysis gives clue to how empagliflozin cuts cardiovascular risk, and study findings challenge cholesterol guidelines for patients with type 1 diabetes. Also, we take a closer look at how smoke-free policies affect blood pressure, and how magazine-ranked “Best Hospitals” actually perform.

Subscribe to Cardiocast wherever you get your podcasts.
Amazon Alexa
Apple Podcasts

Recommended Reading

Novel formulation for childhood ADHD
MDedge Cardiology
Invasive strategy increased bleeding risk in frail older AMI patients
MDedge Cardiology
Black Friday edition: All on exercise
MDedge Cardiology
AHA 2018: Part II
MDedge Cardiology
Empagliflozin and left ventricular mass
MDedge Cardiology
TKR after arthroscopic surgery
MDedge Cardiology
Probiotics and pediatric gastroenteritis
MDedge Cardiology
Smoke-free policy and blood pressure
MDedge Cardiology
Pot and Pain? We’ll see
MDedge Cardiology
Physical activity for women who lose weight
MDedge Cardiology